Get the Stockscreener App
47.31
0.04%
-0.02
After Hours:
47.33
0.02
+0.04%
Genedx Holdings Corp stock is traded at $47.31, with a volume of 1.09M.
It is down -0.04% in the last 24 hours and down -32.25% over the past month.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$47.33
Open:
$48.59
24h Volume:
1.09M
Relative Volume:
0.95
Market Cap:
$1.40B
Revenue:
$442.68M
Net Income/Loss:
$-77.81M
P/E Ratio:
-17.73
EPS:
-2.6684
Net Cash Flow:
$-28.65M
1W Performance:
+16.10%
1M Performance:
-32.25%
6M Performance:
-67.72%
1Y Performance:
-29.73%
1-Day Range:
$45.35
$49.19
1-Week Range:
$40.86
$49.43
52-Week Range:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
47.31 | 1.41B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-15-25 | Initiated | Guggenheim | Buy |
| May-09-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
View All
Genedx Holdings Corp Stock (WGS) Latest News
WGS stock slumps after hours as firm predicts lower test volume for year - MSN
GeneDx a new overweight at Piper Sandler on rare diseases testing market - MSN
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - The Motley Fool
Prosight Management Acquires $42.72 Million Stake in GeneDx Holdings - Intellectia AI
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - The Motley Fool
Casdin, Meister disclose sizable GeneDx (WGS) ownership positions - Stock Titan
WGS News | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares? - Yahoo Finance
Casdin Partners master fund buys $21.5 million in GeneDx stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $21.5 million in GeneDx stock - Investing.com India
Casdin-linked funds add 500K GeneDx (WGS) shares in open-market buys - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
GeneDx Holdings (WGS) price target decreased by 32.59% to 98.94 - MSN
Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud - marketscreener.com
GeneDx Holdings Corp. (WGS) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
GeneDx (WGS) 10K Form and Latest SEC Filings 2026 - MarketBeat
GeneDx faces securities fraud probe after missing revenue targets and stock plunges 49%. - Pluang
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Law firm investigates GeneDx after shares plunge 50% on weak earnings and lowered guidance - Pluang
Bragar Eagel & Squire, P.C. is Investigating GeneDx - GlobeNewswire
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - The Chronicle-Journal
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Does GENEDX HOLDINGS (WGS) Have the Potential to Rally 26.17% as Wall Street Analysts Expect? - MSN
GeneDx Holdings Insider Bought Shares Worth $13,765,345, According to a Recent SEC Filing - marketscreener.com
A Look At GeneDx Holdings (WGS) Valuation After Q1 2026 Reset And Securities Investigation - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdin - The National Law Review
(WGS) Risk Channels and Responsive Allocation - Stock Traders Daily
Comerica Bank Sells 29,753 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Fraud Probes And Guidance Cut Put Valuation Gap In Focus - simplywall.st
Number of shareholders of GeneDx Holdings Corp. – NASDAQ:WGS - TradingView
A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation - Yahoo Finance
GeneDx Holdings (WGS) upgraded to strong buy: Here's what you should know - MSN
UBS Group AG Decreases Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Corvex management, director Keith Meister buy $13.7m GeneDx stock By Investing.com - Investing.com South Africa
Corvex management, director Keith Meister buy $13.7m GeneDx stock - Investing.com India
Corvex-linked funds boost GeneDx (WGS) stake with 351K-share open-market buy - Stock Titan
Casdin and Meister report 12% and 17.9% GeneDx (WGS) stakes - Stock Titan
GeneDx (NASDAQ:WGS) Shares Up 6.9%Still a Buy? - MarketBeat
GeneDx WGS Slides On Guidance Cut As Insiders Buy The Dip - StocksToTrade
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth - MSN
GeneDx Q1 2026 misses targets; lower-margin genomic tests slow growth, but turnaround potential remains. - Pluang
GeneDx (WGS) Fell Despite Continued Execution Improvement - Insider Monkey
Levi & Korsinsky Announces Investigation of Securities Claims Against GeneDx Holdings Corp. (WGS) - GlobeNewswire
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):